Code | CSB-EL021086HU |
Size | 96T,5×96T,10×96T |
Price | Request a Quote |
Trial Size |
24T ELISA Kit Trial Size (Only USD$150/ kit) * Sample kit cost can be deducted as a $30 credit for each 96-assay kit of the same analyte and brand you subsequently purchase within six months until depleted. More details >> Interested in a trial size? Please leave a message below.
|
Have Questions? | Leave a Message or Start an on-line Chat |
Intra-assay Precision (Precision within an assay): CV%<8% | ||||||
Three samples of known concentration were tested twenty times on one plate to assess. | ||||||
Inter-assay Precision (Precision between assays): CV%<10% | ||||||
Three samples of known concentration were tested in twenty assays to assess. | ||||||
To assess the linearity of the assay, samples were spiked with high concentrations of human SERPING1 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay. | ||||||
Sample | Serum(n=4) | |||||
1:200 | Average % | 99 | ||||
Range % | 95-103 | |||||
1:400 | Average % | 94 | ||||
Range % | 91-98 | |||||
1:800 | Average % | 95 | ||||
Range % | 90-100 | |||||
1:1600 | Average % | 92 | ||||
Range % | 85-96 |
The recovery of human SERPING1 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section. | ||||||
Sample Type | Average % Recovery | Range | ||||
Serum (n=5) | 96 | 88-99 | ||||
EDTA plasma (n=4) | 89 | 82-96 | ||||
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]()
|
SERPING1, also known as C1 inhibitor, is a serine protease inhibitor that regulates multiple proteolytic cascades including the complement, coagulation, fibrinolytic, and kallikrein-kinin systems. This protein serves as the primary inhibitor of C1r and C1s proteases in the classical complement pathway, preventing excessive complement activation and subsequent tissue damage. SERPING1 deficiency or dysfunction is associated with hereditary angioedema, a rare genetic disorder characterized by recurrent episodes of localized swelling. The protein's regulatory role in inflammatory pathways makes it a valuable biomarker for various immune-mediated conditions and complement-related disorders.
The Human Plasma protease C1 inhibitor ELISA kit (CSB-EL021086HU) uses a competitive quantitative assay principle to measure SERPING1 levels in serum, plasma, and tissue homogenates. The kit offers a detection range of 18.75 ng/mL to 1200 ng/mL with a sensitivity of 4.7 ng/mL. Each assay requires 50-100 μL sample volume and can be completed within 1-5 hours. Detection occurs at 450 nm wavelength, providing reliable quantification of human SERPING1 concentrations for research applications.
Application Examples
Note: The following application examples are drawn from a selection of publications citing this product. For additional applications, please refer to the full list of references in the "Citations" section.
This ELISA kit has been used in proteomics validation studies to confirm differentially expressed proteins identified through serum analysis. Researchers have applied the kit to quantify target protein levels in human serum samples as part of biomarker profiling studies. The assay serves as a validation tool for proteomic discoveries. It also supports studies examining protein expression changes in clinical research contexts.
• Proteomics validation: Confirmation of differentially expressed proteins identified through initial serum proteomics screening approaches
• Biomarker research: Quantitative measurement of target protein concentrations in human serum samples for biomarker development studies
• Complement system studies: Analysis of complement pathway components in serum samples to examine immune system function
• Clinical research: Comparative protein level analysis between patient groups and control populations in translational medicine studies
There are currently no reviews for this product.